1. 1423PPre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: A positive prognostic factor for survival?. (23rd October 2018) Authors: Prediletto, I; Vasile, E; Bruno, R; Macerola, E; Pasquini, G; Fontanini, G; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Tumor Growth Inhibition Model Based on M‐Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single‐Agent Carfilzomib Use. (20th November 2015) Authors: Jonsson, F; Ou, Y; Claret, L; Siegel, D; Jagannath, S; Vij, R; Badros, A; Aggarwal, S; Bruno, R Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 12(2015:Dec.) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of Tumor Growth Inhibition Metrics to Predict Overall Survival. Issue 2 (13th May 2014) Authors: Claret, L; Bruno, R Journal: Clinical pharmacology & therapeutics Issue: Volume 96:Issue 2(2014) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Biased assessment of gestational age at birth when obstetric gestation is known. Issue 1 (January 1993) Authors: Gagliardi, L; Brambilla, C; Bruno, R; Martinelli, S; Console, V Journal: Archives of disease in childhood Issue: Volume 68:Issue 1(1993)Spec No Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma. Issue 2 (9th June 2017) Authors: Stroh, M; Winter, H; Marchand, M; Claret, L; Eppler, S; Ruppel, J; Abidoye, O; Teng, SL; Lin, WT; Dayog, S; Bruno, R; Jin, J; Girish, S Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 2(2017) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Differential kinetic dynamics and heating of ions in the turbulent solar wind. (2nd December 2016) Authors: Valentini, F; Perrone, D; Stabile, S; Pezzi, O; Servidio, S; Marco, R De; Marcucci, F; Bruno, R; Lavraud, B; Keyser, J De; Consolini, G; Brienza, D; Sorriso-Valvo, L; Retinò, A; Vaivads, A; Salatti, M; Veltri, P Journal: New journal of physics Issue: Volume 18:Number 12(2016:Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Donor hypernatremia is associated with increased mortality after heart transplantation. (3rd October 2022) Authors: Oehler, D; Immohr, M; Boettger, C; Erbel-Khurtsidze, S; Aubin, H; Bruno, R; Holst, T; Horn, P; Westenfeld, R; Kelm, M; Tudorache, I; Akhyari, P; Lichtenberg, A; Boeken, U Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. (March 2021) Authors: Paolucci, Stefania; Cassaniti, Irene; Novazzi, Federica; Fiorina, Loretta; Piralla, Antonio; Comolli, Giuditta; Bruno, Raffaele; Maserati, Renato; Gulminetti, Roberto; Novati, Stefano; Mojoli, Francesco; Baldanti, Fausto; Bruno, R; Mondelli, M; Brunetti, E; Di Matteo, A; Seminari, E; Maiocchi, L;... Journal: International journal of infectious diseases Issue: Volume 104(2021) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials. Issue 4 (13th January 2014) Authors: Bruno, R; Mercier, F; Claret, L Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 4(2014) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients With Non–Small Cell Lung Cancer Based on MONET1 Study Results. Issue 4 (17th January 2014) Authors: Claret, L; Bruno, R; Lu, J‐F; Sun, Y‐N; Hsu, C‐P Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 4(2014) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗